Literature DB >> 21311355

Effect of l-arginine infusion on glucose disposal during exercise in humans.

Kelly C Linden1, Glenn D Wadley, Andrew P Garnham, Glenn K McConell.   

Abstract

PURPOSE: We have previously shown that local infusion of a nitric oxide synthase (NOS) inhibitor attenuates increases in leg glucose uptake during exercise in humans. We have also shown that infusion of the NOS substrate, l-arginine (l-Arg), increases glucose clearance, although the mechanisms involved were not determined. A potential mechanism for NO-mediated glucose disposal is via interactions with NOS and the energy sensor AMP-activated protein kinase (AMPK). The aim of this study was to determine the mechanism(s) by which l-Arg infusion increases glucose disposal during exercise in humans by examining total NOS activity and AMPK signaling.
METHODS: Seven males cycled for 120 min at 64% ± 1% VO(2)peak, during which the [6,6-H]glucose tracer was infused. During the final 60 min of exercise, either saline alone (Control, CON), or saline containing l-Arg HCl (l-Arg, 30 g at 0.5 g·min(-1)) was coinfused in a double-blind, randomized, counterbalanced order.
RESULTS: l-Arg increased the glucose rate of disappearance and glucose clearance rate during exercise; however, this was accompanied by a 150% increase in plasma insulin concentration from 65 to 75 min (P < 0.05) that remained significantly elevated until 90 min of exercise. Skeletal muscle AMPK signaling, nNOSμ phosphorylation by AMPK, and total NOS activity increased to a similar extent in the two trials.
CONCLUSIONS: The increase in glucose disposal after l-Arg infusion during exercise is likely due to the significantly higher plasma insulin concentration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311355     DOI: 10.1249/MSS.0b013e318212a317

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

1.  Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase's type 5 inhibitors on DHT response to exercise-related stress.

Authors:  P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2020-09-18       Impact factor: 4.256

2.  L-Arginine but not L-glutamine likely increases exogenous carbohydrate oxidation during endurance exercise.

Authors:  David S Rowlands; Jim Clarke; Jackson G Green; Xiaocai Shi
Journal:  Eur J Appl Physiol       Date:  2011-11-03       Impact factor: 3.078

3.  Factors Influencing AMPK Activation During Cycling Exercise: A Pooled Analysis and Meta-Regression.

Authors:  Jeffrey A Rothschild; Hashim Islam; David J Bishop; Andrew E Kilding; Tom Stewart; Daniel J Plews
Journal:  Sports Med       Date:  2021-12-08       Impact factor: 11.928

4.  No effect of acute L-arginine supplementation on O₂ cost or exercise tolerance.

Authors:  Anni Vanhatalo; Stephen J Bailey; Fred J DiMenna; Jamie R Blackwell; Gareth A Wallis; Andrew M Jones
Journal:  Eur J Appl Physiol       Date:  2013-02-20       Impact factor: 3.078

5.  Skeletal muscle AMPK is not activated during 2 h of moderate intensity exercise at ∼65% V ̇ O 2 peak in endurance trained men.

Authors:  Glenn K McConell; Glenn D Wadley; Kieran Le Plastrier; Kelly C Linden
Journal:  J Physiol       Date:  2020-07-27       Impact factor: 5.182

6.  Nontargeted Metabolomic Analysis of Plasma Metabolite Changes in Patients with Adolescent Idiopathic Scoliosis.

Authors:  Lige Xiao; Guanteng Yang; Hongqi Zhang; Jinyang Liu; Chaofeng Guo; Yang Sun
Journal:  Mediators Inflamm       Date:  2021-05-25       Impact factor: 4.711

7.  Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.

Authors:  Anna Kakehashi; Shugo Suzuki; Naomi Ishii; Takahiro Okuno; Yuko Kuwae; Masaki Fujioka; Min Gi; Vasily Stefanov; Hideki Wanibuchi
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.